7 Best Ciclopirox Olamine Suppliers for Global Buyers

Ciclopirox Olamine remains an established topical antifungal ingredient for international pharmaceutical and dermatology supply chains. Buyers often evaluate suppliers by more than price. They need verified identity, consistent assay results, reliable documentation, and practical export support.

Recent analyses from Grand View Research and Mordor Intelligence describe steady demand across the broader antifungal drugs market, supported by dermatology, pharmacy, and hospital applications. However, these reports usually group several active ingredients together. They rarely provide a precise global figure for Ciclopirox Olamine alone. That limitation deserves attention. Market size estimates should not replace supplier-level verification.

This guide reviews seven Ciclopirox Olamine suppliers serving global buyers, with attention to manufacturing capability, quality systems, certifications, and communication standards. A dependable supplier should provide a current certificate of analysis, specification sheet, safety data sheet, batch details, and traceable production information. Buyers should also compare particle characteristics, packaging protection, lead times, and minimum order quantities.

Regulatory expectations vary between the United States, European Union, India, China, and other markets. FDA databases, EMA product information, USP standards, and applicable Good Manufacturing Practice guidance can support a more disciplined review. Documentation alone is not enough. Independent testing may still be sensible for high-volume purchases or new supplier relationships.

No supplier is perfect. Some offer stronger pricing but weaker technical communication. Others provide excellent documents but limited production capacity. This comparison aims to make those differences visible, helping procurement teams select a credible partner for quality-sensitive, compliant, and long-term sourcing.

7 Best Ciclopirox Olamine Suppliers for Global Buyers

Ciclopirox Olamine Profile: CAS 41621-49-2 and 1% Topical Applications

Ciclopirox Olamine, identified by CAS 41621-49-2, is an antifungal active used in 1% topical formulations. It is commonly supplied as a white to off-white powder for creams, gels, lotions, and shampoos. The 1% strength requires careful weighing and uniform dispersion during manufacturing. Small errors can affect batch consistency. Global buyers should confirm identity, assay, water content, residual solvents, and impurity limits before purchasing.

A reliable supplier should provide a current Certificate of Analysis, Safety Data Sheet, specification sheet, and traceable batch documents. GMP-based production is preferable, but certificates alone do not prove consistent quality. Review manufacturing-site details, stability data, packaging protection, and retest practices. Practical sourcing experience shows that moisture exposure can complicate storage, especially during long ocean shipments. Temperature and humidity records are worth requesting. Regulatory acceptance also differs by market, so buyers must verify the intended 1% topical use with local authorities and qualified professionals.

Tips: Request a representative sample before placing a large order. Compare the sample against the specification, not only the sales quotation. Ask about lead time, minimum order quantity, and change-notification procedures. One point is often overlooked: a low price may reflect weaker documentation, not better efficiency. Supplier evaluation should balance quality evidence, technical support, delivery reliability, and transparent communication.

Ciclopirox Olamine Profile: CAS 41621-49-2 and 1% Topical Applications

Ciclopirox olamine is an antifungal active ingredient commonly supplied in 1% topical formulations. The chart compares the labeled active concentration across representative topical dosage forms.

CAS Number
41621-49-2
Molecular Formula
C14H24N2O3
Molecular Weight
268.35 g/mol
Typical Topical Strength
1% w/w or w/v

The 1% strength is used in topical creams, gels, lotions, solutions, and shampoos. Product availability, labeling, and approved indications can differ by country and dosage form.

Global Supplier Screening: GMP, DMF, CEP, and ICH Q7 Compliance

When screening the 7 best ciclopirox olamine suppliers, documentation should outweigh catalogue claims. GMP certification is only a starting point. Audit its issuing body, scope, expiry date, and manufacturing address. The WHO estimates that one in ten medicines in low- and middle-income countries may be substandard or falsified. That figure makes traceable quality systems essential, not decorative paperwork.

Request the active ingredient’s DMF status, letter of access, and change-control history. A CEP can support European quality assessment, but it does not replace supplier qualification or batch testing. ICH Q7 expects controlled raw materials, validated processes, deviation management, and complete records. Check whether the supplier can provide recent impurity profiles, residual-solvent results, stability data, and three consistent batch certificates. Small gaps matter.

FDA’s 2023 Drug Shortages Annual Report linked many shortages to manufacturing and quality problems. For global buyers, that finding supports dual sourcing and capacity checks. Ask about annual production volume, reserve capacity, and typical lead times. Inspect temperature logs, warehouse segregation, and electronic data controls during an audit. Remote reviews help, but they are imperfect. I would not accept a polished certificate without evidence of current operations. Reassess suppliers after major process changes, regulatory observations, or unexplained specification trends.

7 Best Ciclopirox Olamine Suppliers for Global Buyers - Global Supplier Screening: GMP, DMF, CEP, and ICH Q7 Compliance
Shortlist Profile API Scope CAS Number Molecular Formula Relative Molecular Mass GMP Evidence DMF Readiness CEP Evidence ICH Q7 Alignment Quality Documentation Requested Global Buyer Screening Result
Supplier Profile 01 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Confirm site, scope, expiry, and issuing authority.
Required
Confirm US DMF status, authorization letter, and current open-part information.
Required
Verify CEP number, holder, covered specification, and validity with EDQM records.
Applicable
Request an ICH Q7 compliance statement and latest audit history.
CoA, specification, residual-solvent limits, elemental-impurity assessment, stability data, change-control procedure. Pending documentary review
Supplier Profile 02 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Check whether certification covers commercial API manufacture.
Required
Confirm DMF submission region, lifecycle status, and response capability for deficiencies.
Required
Verify whether the certificate covers the buyer's intended route and grade.
Applicable
Assess quality-system controls against ICH Q7 principles.
Manufacturing-flow chart, process-validation summary, impurity profile, analytical-method validation, audit questionnaire. Pending documentary review
Supplier Profile 03 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Confirm manufacturing address and inspection history.
Required
Request DMF reference, signed letter of access, and applicant-support procedure.
Required
CEP availability must be confirmed directly through current EDQM documentation.
Applicable
Review deviation, CAPA, OOS, and supplier-qualification systems.
GMP certificate, audit report or summary, batch records, packaging specification, transport and storage conditions. Pending documentary review
Supplier Profile 04 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Verify certificate authenticity and product-specific scope.
Required
Confirm whether the DMF is active and supports the target market.
Required
Request certificate copy or official confirmation before qualification.
Applicable
Confirm controlled storage, traceability, and batch-release procedures.
Current CoAs, three-batch consistency data, retest period, stability protocol, microbial-control statement where applicable. Pending documentary review
Supplier Profile 05 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Confirm regulator, inspection date, and certificate expiry.
Required
Check DMF compatibility with the buyer's regulatory filing strategy.
Required
Determine whether CEP coverage matches the proposed specification.
Applicable
Evaluate process controls, cleaning validation, and change notification.
Declaration of elemental impurities, nitrosamine risk assessment, residual-solvent data, allergen statement, GMP questionnaire. Pending documentary review
Supplier Profile 06 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Confirm that the certificate applies to the actual production site.
Required
Request DMF status, regulatory-contact details, and change-control commitments.
Required
CEP status must be independently validated before approval.
Applicable
Review data-integrity controls, batch-release authority, and complaint handling.
Site-master-file summary, quality agreement template, validation matrix, supply-continuity plan, recall procedure. Pending documentary review
Supplier Profile 07 Ciclopirox olamine API 41621-49-2 C14H24N2O3 268.36 g/mol Certificate to be verified
Confirm inspection outcome and scope for the listed API.
Required
Verify DMF availability, letter-of-access process, and regulatory support.
Required
Confirm current CEP details with the official certificate holder.
Applicable
Assess compliance with ICH Q7-based API quality-management practices.
Specifications, validated methods, impurity and degradation profiles, stability commitment, packing and labeling controls. Pending documentary review
Regulatory note: GMP certification, DMF availability, CEP status, and ICH Q7 compliance are site-, product-, jurisdiction-, and time-specific. Each status should be independently verified using current certificates, official regulatory records, and supplier-controlled quality documents before qualification or purchase.

Ranking Seven Suppliers by MOQ, Lead Time, Capacity, and Batch Consistency

For global buyers, the seven best ciclopirox olamine suppliers should be ranked beyond price. MOQ, lead time, production capacity, and batch consistency reveal real sourcing strength. A low MOQ helps smaller manufacturers test demand without excessive inventory. However, unusually short lead times deserve careful verification.

The ranking should examine standard and custom MOQs, typical delivery windows, annual capacity, and supply records. Ask for recent certificates of analysis, GMP evidence, impurity profiles, and stability data. Batch consistency matters greatly. Compare assay results, particle size, moisture levels, and packaging conditions across several lots. A supplier may perform well once, then struggle during peak production. That possibility should not be ignored.

Tips: Request three consecutive batch documents before approval. Confirm whether quoted lead times include testing, release, and export documentation. Review how the supplier handles deviations and rejected batches. A video audit or qualified third-party inspection can expose storage problems that paperwork misses. Keep a written scorecard, but allow room for judgment. Numbers can look perfect while communication remains slow or unclear. During my own sourcing reviews, response quality often predicted future reliability better than a slightly lower MOQ. This is not a flawless measure, but it is useful evidence. Ensure every purchase follows applicable quality, customs, and pharmaceutical regulations in the destination market.

Quality Verification Through COA, HPLC Assay, Impurity, and Stability Data

7 Best Ciclopirox Olamine Suppliers for Global Buyers

Reliable supplier selection begins with evidence, not attractive specifications. For ciclopirox olamine, request a current Certificate of Analysis for the exact batch offered. Check the batch number, manufacturing date, retest date, test methods, and authorized approval. The HPLC assay should clearly state the result, reference standard, and acceptance range. A vague “complies” statement is not enough.

Impurity data deserves careful review. Ask for identified and unidentified impurity results, chromatograms, and method validation details. Confirm that the reported limits match your intended quality requirements and technical documentation. Stability data should include storage conditions, testing intervals, packaging type, and results for assay, appearance, and impurities. Accelerated data can reveal risks, but long-term data gives stronger confidence. I have seen documents look complete while missing the original chromatogram. That gap matters.

Tips: Compare at least three batches, not one. Verify that the COA, HPLC report, and stability records describe the same material. Consider independent laboratory testing before large-volume purchasing. Also inspect transport conditions, because heat and moisture exposure may affect quality. No document replaces practical verification. Suppliers should answer technical questions clearly, provide traceable records, and explain any result that seems inconsistent. Small discrepancies should not be ignored.

Global Procurement Review: Incoterms, Regulatory Files, and Supply Risks

For global buyers evaluating the seven best ciclopirox olamine suppliers, procurement quality starts before price. A low quote can hide unclear freight duties, weak documentation, or unstable production. Request the supplier’s proposed Incoterm, shipment point, insurance scope, and delivery responsibility. FOB, CIF, and DDP can create very different landed costs. Confirm the named place in writing. Small wording differences matter.

A reliable supplier should provide a current specification, certificate of analysis, safety data sheet, and manufacturing-site information. Ask about GMP controls, batch traceability, retest periods, and analytical methods. Regulatory files may include impurity profiles, stability data, and declarations relevant to the destination market. Do not assume one dossier fits every country. It often does not. Have a qualified regulatory professional review gaps before purchase approval.

Supply risk deserves equal attention. Check minimum order quantities, lead times, backup manufacturing capacity, and packaging protection during ocean transport. Request recent evidence of batch consistency, not only a polished sample. A supplier may pass one audit and still struggle during peak demand. I have learned that forecast sharing helps, but forecasts are imperfect. Build a second-source plan, define change-notification duties, and agree on actions for delayed or nonconforming batches. Keep payment milestones linked to verified documents and inspection results. That discipline costs more upfront, yet it can prevent expensive border delays and production interruptions.